Circulating tumor cells correlate with poorer survival in pancreatic cancer patients

Researchers have found that pancreatic cancer patients who have circulating tumor cells tend to have worse outcomes than patients without circulating tumor cells. Additionally, the team has uncovered evidence that not all circulating tumor cells are the same, and some may predict worse outcomes than others.

Read the whole article on Science Daily

More from Science Daily